We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
-12.46%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.49B
AUM Growth
–
Cap. Flow
+$3.74B
Cap. Flow
% of AUM
107.01%
Top 10 Holdings %
Top 10 Hldgs %
4.83%
Holding
572
New
572
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$23.8M |
| 2 |
Prologis
PLD
|
+$17.5M |
| 3 |
Check Point Software Technologies
CHKP
|
+$17.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$16.9M |
| 5 |
Gartner
IT
|
+$16.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 14.02% |
| 4 | Consumer Discretionary | 12.17% |
| 5 | Industrials | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
McKesson
MCK
$105B
| $24.3M | 0.7% |
+74,500
| New | +$23.8M |
|
|
2
Vertex Pharmaceuticals
VRTX
$130B
| $17.8M | 0.51% |
+63,100
| New | +$16.9M |
|
3
General Mills
GIS
$19.6B
| $17.2M | 0.49% |
+228,400
| New | +$16M |
|
|
4
Check Point Software Technologies
CHKP
$14.1B
| $16.5M | 0.47% |
+135,500
| New | +$17.4M |
|
5
Eli Lilly
LLY
$1.01T
| $16M | 0.46% |
+49,400
| New | +$14.8M |
|
6
AutoZone
AZO
$46.7B
| $15.7M | 0.45% |
+7,300
| New | +$15M |
|
7
Bristol-Myers Squibb
BMY
$130B
| $15.4M | 0.44% |
+200,400
| New | +$15.3M |
|
8
Pfizer
PFE
$157B
| $15.3M | 0.44% |
+291,300
| New | +$14.8M |
|
9
Merck
MRK
$355B
| $15.3M | 0.44% |
+167,300
| New | +$14.8M |
|
10
CVS Health
CVS
$121B
| $15.2M | 0.44% |
+164,200
| New | +$16M |
|
|
11
Gartner
IT
$12.4B
| $15.1M | 0.43% |
+62,600
| New | +$16.7M |
|
|
12
Prologis
PLD
$129B
| $14.9M | 0.43% |
+126,500
| New | +$17.5M |
|
13
W.W. Grainger
GWW
$59.8B
| $14.8M | 0.42% |
+32,500
| New | +$15.8M |
|
14
AbbVie
ABBV
$465B
| $14.6M | 0.42% |
+95,600
| New | +$14.6M |
|
15
Elevance Health
ELV
$90.6B
| $14.4M | 0.41% |
+29,900
| New | +$14.8M |
|
16
Masco
MAS
$13.6B
| $14.1M | 0.4% |
+278,200
| New | +$14.7M |
|
17
Cigna
CI
$76.3B
| $14.1M | 0.4% |
+53,400
| New | +$13.8M |
|
18
IQVIA
IQV
$44.4B
| $14M | 0.4% |
+64,600
| New | +$14M |
|
19
Fair Isaac
FICO
$21.3B
| $14M | 0.4% |
+34,800
| New | +$13.7M |
|
20
Paychex
PAYX
$42.1B
| $13.8M | 0.4% |
+121,400
| New | +$15.2M |
|
21
Waters Corp
WAT
$41B
| $13.7M | 0.39% |
+41,500
| New | +$13.2M |
|
22
Amgen
AMGN
$203B
| $13.7M | 0.39% |
+56,300
| New | +$13.8M |
|
23
Expeditors International
EXPD
$25.2B
| $13.7M | 0.39% |
+140,100
| New | +$14.4M |
|
24
Lennox International
LII
$12.5B
| $13.6M | 0.39% |
+66,000
| New | +$14.4M |
|
25
UnitedHealth
UNH
$337B
| $13.6M | 0.39% |
+26,400
| New | +$13.3M |
|
Similar funds
PPFA
MCCA
EC
JSW
USCWA
EPIM
RBA
EWA
Andra AP-fonden's Q2 2022 Portfolio in Review
As of Q2 2022, Andra AP-fonden held 572 positions worth $3.49B. Its ten largest holdings account for 4.8% of the portfolio.
Andra AP-fonden deployed $3.74B of net new capital in Q2 2022, opening 572 new positions. Its largest new stake was McKesson: 74,500 shares worth $24.3M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, followed by Healthcare and Financials.
- Andra AP-fonden's largest Q2 2022 buy was McKesson: 74,500 shares worth $24.3M.
- Andra AP-fonden's ten largest holdings make up 4.8% of its $3.49B portfolio in Q2 2022.
- Andra AP-fonden opened 572 new positions and closed 0 in Q2 2022.
Based on Andra AP-fonden's 13F filing for Q2 2022, filed 15 Aug 2022.